Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SUPREME COURT REMANDS MITCHELL V. COLLAGEN PMA PREEMPTION CASE, SETTING STAGE FOR EARLY TEST OF MEDTRONIC V. LOHR'S EFFECT ON PMA DEVICES

This article was originally published in The Gray Sheet

Executive Summary

The Supreme Court July 1 instructed a lower court to re-review Mitchell v. Collagen Corp., a case involving liability claims against a device approved through FDA's premarket approval application process. The move sets up one of the first tests of how the Court's recent ruling against 510(k) preemption in Medtronic v. Lohr will be applied by lower courts to PMA-approved products.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006328

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel